Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Total Loss Trends Emerge Amidst the Pandemic
Every industry has been impacted by actions taken to control the spread of COVID-19, including the automotive industry.
Workers' Comp
Blog
Networks Support Telemedicine for Continued Care
“Our offices are temporarily closed due to COVID-19.”This is the message many people received when contacting th
Auto Physical Damage
Article
Reduce In-Person Interactions and Improve Efficiency with Virtual Claims
In March, Ryan Mandell, director of Claims Performance for Mitchell’s Auto Physical Damage business unit, identified the market drivers converging
Mitchell
Article
COVID-19 Ripple Effect on Auto Insurance Market
After months of sheltering in place, it should come as no surprise that claims volumes are down.
Workers' Comp
News Release
The Self Insurer: Work Comp's Virtual Touch
By Bruce Shutan, The Self Insurer
Workers' Comp
Article
What COVID-19 Is Teaching Us About Mental Health
Pandemic anxiety, depression and isolation gives us a taste of what employees face in overcoming a work injury Americans have come a long